Expired Canadian patentCanada
Mimicking peptides in cancer therapy
CA 2233447 C · Owner: Apostolopoulos, Vasso · Inventors: Sandrin, Mauro Sergio; Apostolopoulos, Vasso; Mckenzie, Ian Farquar Campbell
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Peptide mimicks of MUC1 or other cancer peptides which can be included in cancer vaccines and used in therapeutic methods for the treatment of cancer patients.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 27, 1996 and granted November 29, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 27, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 27, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 27, 1996
GrantedNovember 29, 2011
Term endedSeptember 27, 2016
Patent numberCA 2233447 C
Classification (IPC)A61K39/00 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.